Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Incontinence, prolapse & sacral neuromodulation · Arizona | Incontinence, prolapse & sacral neuromodulation · California | |
|---|---|---|
| Surgeons, 2024 | 38 | 73 |
| Medicare fee-for-service cases | 2,602 | 5,242 |
| Growth since 2019 (Medicare FFS) | +2%/yr | +0.1%/yr |
| Forecast cases (Medicare FFS) | 2,760 in 2030 | 6,070 in 2030 |
| Forecast growth | +1%/yr to 2030 | +2.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.5 | 1.6 |
| Medicare Advantage share | 54% | 56% |
| Out of hospital | 38% (+26 pts since 2019) | 20% (+9 pts since 2019) |
| Cases per surgeon | 68 | 72 |
| Top 10 surgeons' share | 58% | 39% |
| Surgeons growing | 8 | 16 |
| New since the base year | 4 | 9 |
| Likely to stop billing it | 7 by 2026 | 21 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $5,169 | $13K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.